Current:Home > InvestCancer drug shortages could put chemo patient treatment at risk-LoTradeCoin
Cancer drug shortages could put chemo patient treatment at risk
View Date:2024-12-23 22:42:30
Chattanooga, Tennessee — Carol Noon has an aggressive form of endometrial cancer. It's treatable, but there is no time to waste.
Due to a drug shortage, she told CBS News "there's no guarantee" that the life-saving chemotherapy drugs she needs will be available throughout the course of her treatment.
The night before her second dose of chemotherapy, the 61-year-old Noon received a call from her doctor to inform her that the hospital had run out of her treatment. Thankfully, Noon got her dose a week later.
"I think it's an emotional rollercoaster," Noon said. "It's very frustrating to know that there's a standard of care, these two generic drugs, and I can't get them."
She said her doctors are "frustrated. "We're not sure what the next steps are. And we're just hoping there's gonna be treatment available."
Patients like Noon are given carboplatin and cisplatin, generic medications that aren't profitable for manufacturers to produce — and few are made in the U.S.
Since the start of the COVID-19 pandemic, the international supply chain for cancer medications has been strained and the situation has become dire. Food and Drug Administration inspectors found "widespread problems" at a factory in India that makes more than half of the U.S. supply of cisplatin.
In March, the FDA reported that Pluvicto — a drug used to treat advanced prostate cancer — is in short supply. Pluvicto is only manufactured in Italy.
And the issue isn't just limited to cancer drugs. A report also released in March by the Senate Homeland Security Committee found that 295 drugs were in short supply in the U.S. last year, marking a five-year high.
"We had to make some decisions about who we were going to prioritize during this difficult time," said oncologist Dr. Kari Wisinski with the University of Wisconsin Health, who told CBS News she had never seen a shortage this serious.
"The question is, could people die because of this shortage?" Wisinksi asked. "I think it all depends on how long it occurred. If we experienced a prolonged shortage of chemotherapy, then yes, I do think people could die."
In response, the FDA last month temporarily began importing cisplatin from a Chinese drug manufacturer Qilu Pharmaceutical, which is not FDA approved.
"Someday, I'm gonna die," Noon said. "I really would rather not die because these standard generic drugs weren't available to me. And I can't imagine being in that position and questioning what happened, my family having that doubt and my friends having that doubt. Was it the cancer, or was it that there was not enough chemotherapy and it got rationed."
- In:
- Food and Drug Administration
- Cancer
Norah O'Donnell is the anchor and managing editor of the "CBS Evening News." She also contributes to "60 Minutes."
TwitterveryGood! (378)
Related
- Can I take on 2 separate jobs in the same company? Ask HR
- Miami police prepare for protesters outside courthouse where Trump is being arraigned
- 48 Hours podcast: Married to Death
- Ariana Madix Reveals the Shocking First Time She Learned Tom Sandoval and Raquel Leviss Had Sex
- Kalen DeBoer, Jalen Milroe save Alabama football season, as LSU's Brian Kelly goes splat
- Today's Hoda Kotb Says Daughter Hope Has a Longer Road Ahead After Health Scare
- Ukraine: The Handoff
- Jill Biden had three skin lesions removed
- Oregon's Dan Lanning, Indiana's Curt Cignetti pocket big bonuses after Week 11 wins
- UN Proposes Protecting 30% of Earth to Slow Extinctions and Climate Change
Ranking
- Tuskegee University closes its campus to the public, fires security chief after shooting
- Check Out the 16-Mile Final TJ Lavin Has Created for The Challenge: World Championship Finalists
- Eva Mendes Proves She’s Ryan Gosling’s No. 1 Fan With Fantastic Barbie T-Shirt
- Federal Report Urges Shoring Up Aging Natural Gas Storage Facilities to Prevent Leaks
- 12 college students charged with hate crimes after assault in Maryland
- At the first March for Life post-Roe, anti-abortion activists say fight isn't over
- 988 Lifeline sees boost in use and funding in first months
- U.S. announces $325 million weapons package for Ukraine as counteroffensive gets underway
Recommendation
-
Stock market today: Asian shares mostly decline, shrugging off Wall Street’s overnight rally
-
Martha Stewart Reacts to Landing Sports Illustrated’s Swimsuit Cover at Age 81
-
Conspiracy theorists hounded Grant Wahl's family when he died. Now they're back
-
E. Jean Carroll can seek more damages against Trump, judge says
-
Today’s Savannah Guthrie, Al Roker and More React to Craig Melvin Replacing Hoda Kotb as Co-Anchor
-
Army Corps Halts Dakota Access Pipeline, Pending Review
-
Your kids are adorable germ vectors. Here's how often they get your household sick
-
Can Trump Revive Keystone XL? Nebraskans Vow to Fight Pipeline Anew